News

Pot tied to increased risk of substance use disorders, not depression or anxiety


 

FROM JAMA PSYCHIATRY

References

Cannabis use is associated with an increased risk of later addiction to cannabis, alcohol, and other drugs, a longitudinal survey of almost 35,000 adults shows.

Dr. Carlos Blanco and his associates analyzed two waves of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) from 2001-2002 and 2004-2005. They found that, among respondents who used cannabis in the past 12 months, the risk of developing any substance use disorder (odds ratio, 8; 95% confidence interval, 6.9-9.2) was higher than the risk of developing any mood (OR, 2.1; 95% CI, 1.8-2.0) or anxiety disorder (OR, 1.9; CI, 1.6-2.3). Similar trends were found for the risk of alcohol use disorder (OR, 7.3; 95% CI, 6.3-8.6) and nicotine dependence (OR, 4.2; 95% CI, 3.6-4.9). The investigators also found a dose-response effect; more frequent cannabis use was tied to a greater risk of later addiction.

Smithore

Together, the findings suggest caution in implementing policies tied to the legalization of cannabis for recreational use, noted Dr. Blanco of the National Institute on Drug Abuse, Bethesda, Md. Adverse outcomes such as substance use disorders “should be taken under careful consideration in clinical care and policy planning.”

Find the full study in JAMA Psychiatry: (2016 Feb 17. doi: 10.1001/jamapsychiatry.2015.3229)

llaubach@frontlinemedcom.com

Recommended Reading

Clinical Guidelines: USPSTF guidelines for treatment of tobacco dependence (2015)
MDedge Internal Medicine
One clinic at a time: Kentucky doctor works to change opioid prescribing
MDedge Internal Medicine
Practice guideline released for treating opioid use disorder
MDedge Internal Medicine
DEA’s rescheduling of hydrocodone tied to declines in prescribing
MDedge Internal Medicine
Physicians’ odds of beating addiction higher
MDedge Internal Medicine
Lifetime use of pot affects verbal memory in middle-aged adults
MDedge Internal Medicine
FDA announces new plan to combat opioid abuse
MDedge Internal Medicine
NIDA releases strategic plan to prevent, treat substance use disorders
MDedge Internal Medicine
ThriveNYC could help treat and destigmatize mental, behavioral disorders
MDedge Internal Medicine
Designer drug symptoms can mimic schizophrenia, anxiety, depression
MDedge Internal Medicine